Regulatory filing 📈 Stocks 🌍 United States

QT Imaging Holdings Files Investor Presentation Detailing Business Strategy

QT Imaging Holdings published an investor presentation in November 2026, detailing its breast imaging technology, non-GAAP financial definitions, and forward-looking business strategy.

📅 November 12, 2026 🕐 1 min read

1 assets impacted (Stocks). Net bias: 0 Bullish, 0 Bearish, 1 Neutral. Strongest signal: QTI → 2/10 (55% confidence).

📊 Affected Assets (1)

QTI

Neutral 🤖 55%

📅 Short-term 🌍 US · Explicit

The company filed an 8-K containing an investor presentation dated November 2026, covering its Breast Acoustic CT Scanner and non-GAAP EBITDA definitions, with financial metrics referenced from the November 10, 2026 8-K. The excerpt contains only disclaimers, legal boilerplate and general forward-looking statements, with no new hard figures, guidance changes or approvals that would move the stock.

🧭 Full analysis of these assets

🎯 Key Takeaways

The company references financial metrics and reconciliations of EBITDA and Adjusted EBITDA from its November 10, 2026, Form 8-K filing.
The FDA determined the QT Breast Scanner was substantially equivalent to a predicate device on June 6, 2017.
The presentation outlines a business strategy involving a SaaS pricing model and commercialization efforts in Saudi Arabia and the UAE.

📝 Executive Summary

QT Imaging Holdings, Inc. has released an investor presentation dated November 2026, outlining its strategic focus on the Breast Acoustic CT Scanner and its evolving imaging platform. The document provides definitions for non-GAAP financial measures, including EBITDA and Adjusted EBITDA, and references financial metrics previously disclosed in the company's Form 8-K filed on November 10, 2026.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article